Filling the need for trusted information on national health issues
The Peterson-KFF Health System Tracker provides clear, up-to-date information on trends, drivers and issues that impact the performance of the system. It also illustrates how the U.S. is performing relative to other countries and how different parts of the system are performing relative to one another. A partnership of the Peterson Center on Healthcare and the KFF, the Tracker’s work goal places a heavy emphasis on data and evidence, addressing key questions through collections of charts, which provide data with additional context and synthesis of the latest research and developments. The Tracker also provide regular insight briefs for a more in-depth look at topical questions.
This chart collection summarizes what is known so far about how health costs and utilization have changed during the COVID-19 pandemic. Health spending is on track to be somewhat lower in 2020 than in 2019 – the first time that’s happened since the government started tracking it.
The coronavirus outbreak has hit densely populated urban areas of the United States first and hardest. Some health systems have experienced surges of patients, raising concerns that there are not enough hospital beds, staffing, and equipment. The novel coronavirus was slower to spread to rural areas in the U.S., but…
In spite of a new price transparency rule that requires hospitals to publish the prices of common health services, comparing prices across hospitals remains challenging due to limited compliance with the law and a lack of standardization in the available data, a new KFF analysis finds. The federal rule, which…
A new issue brief examines compliance with a new federal price transparency rule and variation in payer-negotiated rates at U.S. hospitals. The analysis looks at the websites of the two largest hospitals in each state and the District of Columbia, and finds that a lack of consistency in the data…
A new issue brief reviews excess death rates in the U.S. and peer countries by age groups to examine how the pandemic has affected excess mortality rate among younger people. The analysis looks specifically at the excess deaths that arose in 2020 to examine how the age at death during…
A new KFF issue brief examines 2020 data on excess mortality – the number of deaths above what is expected in a typical year – and finds that among similarly large and wealthy nations, the United States had the highest premature excess mortality rate in 2020, indicating that younger people…
This chart collection summarizes what is known so far about how health costs and utilization have changed during the COVID-19 pandemic. Health spending is on track to be somewhat lower in 2020 than in 2019 – the first time that’s happened since the government started tracking it.
A updated issue brief examines the most recent data on deaths from COVID-19 and other causes, and finds that COVID-19 is currently the number one cause of death in the United States. As of February 20, 2021, an average of more than 2,400 people per day died of COVID-19 in…
A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common services on their websites. A second…
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.
